99 Safety of HSG with oil-based contrast medium 5 78. Norris, S., 1956. The hysterogram in study of sterility. Canad 75, 1016–1020. 79. Novak, J., 1930. Salpingographie oder Tubendurchblasung? Zentralbl. Gynakol. 54, 3013–3017. 80. Nugent, D., Watson, A.J., Killick, S.R., Balen, A.H., Rutherford, A.J., 2002. A randomized controlled trial of tubal flushing with lipiodol for unexplained infertility. Fertil. Steril. 77, 173–175. https://doi.org///dx.doi.org/10.1016/S0015-0282%2801%2902925-9 81. Omoto, A., Kurimoto, C., Minagawa, M., Shozu, M., 2013. A case of fetal goiter that resolved spontaneously after birth. J. Clin. Endocrinol. Metab. 98, 3910–3911. https://doi.org///dx.doi. org/10.1210/jc.2013-1066 82. Palmer, A., 1960. Ethiodol hysterosalpingography for the treatment of infertility. Fertil. Steril. 11, 311–315. https://doi.org/10.1016/s0015-0282(16)33788-8 83. Pear, B.L., Boyden, F.M., 1967. Intraperitoneal lipid granuloma. Radiology 89, 47–51. 84. Piatt, A.D., 1947. Intravasation of lipiodol during uterosalpingography. Ohio State Med. J. 43, 821–824. 85. Porcher, M.P., 1935. Un incident de salpingographie. Bull. Mem. la Soc. d’Electroradiologie Medicale Fr. 23, 146–147. 86. Rasmussen, F., Justesen, P., Nielsen, D.T., 1987. Therapeutic value of hysterosalpingography with lipiodol ultra fluid. Acta radiol. 28, 319–322. 87. Riche, V., Fayot, G., 1931. Le lipiodiagnostic en gynecologie. Gynecol. Obstet. (Paris). 24, 540–542. 88. Ries, E., 1929. Effect of Lipiodol Injection on the Tubes. Am. J. Obstet. Gynecol. 17, 728–730. 89. Robins, S.., Shapira, A.., 1951. Uterotubography. 90. Rubin, I.C., 1928. Diagnostic use of intra-uterine iodized oil injection combined with the X-rays, as compared to peruterine CO2 insufflations. Radiology 11, 115–125. 91. Rutherford, R.N., 1948. The therapeutic value of repetitive Lipiodal tubal insufflations. West. J. surgery, Obstet. Gynecol. 56, 145–154. 92. Sappey, P., Fabre, H., Jouffrey, A., 1952. Accidental vasculary injection of lipiodol in the course of hysterosalpingography. Gynecol. Obstet. (Paris). 51, 298–300. 93. Sasaki, Y., Kikuchi, A., Murai, M., Kanasugi, T., Isurugi, C., Oyama, R., Sugiyama, T., 2017. Fetal goiter associated with preconception hysterosalpingography using an oil-soluble iodinated contrast medium. Ultrasound Obstet. Gynecol. 49, 275–276. https://doi.org/10.1002/ uog.15902 94. Satoh, M., Aso, K., Katagiri, Y., 2015. Thyroid Dysfunction in Neonates Born to Mothers Who Have Undergone Hysterosalpingography Involving an Oil-Soluble Iodinated Contrast Medium. Horm. Res. Paediatr. 84, 370–375. https://doi.org/10.1159/000439381 95. Schaffer, B., 1954. Post-hysterosalpingographical giant-cell granuloma of the fallopian tubes]. Obstet. Ginecol. Lat. Am. 12, 562–565. 96. Schultze, G.K.F., 1932. Schädigungen und Gahren bei der Hysterosalpingographie. Zeitschrift für Geburtshilfe und Gynaekologie 101, 413–436. 97. Schutte, J.M., Oonk, M.H., van der Ploeg, J.M., 2006. Diagnosis image (258). A women with a “bullet” in the abdomen. Ned. Tijdschr. Geneeskd. 150, 143. 98. Schwabe, M.G., Shapiro, S.S., Haning, R. V, 1983. Hysterosalpingography with oil contrast medium enhances fertility in patients with infertility of unknown etiology. Fertil. Steril. 40, 604–606. 99. Shapiro, J.H., Rubinstein, B., Jacobson, H.G., Popei, H.M., 1957. Pulmonary oil embolism: a complication of hysterosalpingography. Am. J. roentgenoloy, radium Ther. Nucl. Med. 77, 1055–1058. 100. Slater, S., Paz-Carranza, J., Solomons, E., Perlmutter, M., 1959. Effect of hysterosalpingography on assay of thyroid function. Fertil. Steril. 10, 144–149.
RkJQdWJsaXNoZXIy MTk4NDMw